Cholangiocarcinoma screening: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{cholangiocarcinoma}} | {{cholangiocarcinoma}} | ||
{{CMG}};{{AE}} {{PSK}} | {{CMG}};{{AE}} {{F.K}} {{PSK}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for cholangiocarcinoma. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for cholangiocarcinoma. | There is insufficient evidence to recommend routine screening for cholangiocarcinoma. | ||
Latest revision as of 16:02, 29 January 2018
|
Cholangiocarcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangiocarcinoma screening On the Web |
|
American Roentgen Ray Society Images of Cholangiocarcinoma screening |
|
Risk calculators and risk factors for Cholangiocarcinoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Suveenkrishna Pothuru, M.B,B.S. [3]
Overview
There is insufficient evidence to recommend routine screening for cholangiocarcinoma.
Screening
There is insufficient evidence to recommend routine screening for cholangiocarcinoma.